Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
2000 participants
INTERVENTIONAL
2013-04-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rapid Clamp Release Post Trans-radial Cardiac Catheterization
NCT03645837
Postcath Radial Arterial Clamp Time In the CAth Lab
NCT02269722
Accelerated Ambulation After Vascular Access Closure Device
NCT03142126
Comparison of Distal and Proximal Radial Artery Patency Following Coronary Catheterization, A Real Look at a Special Community
NCT07138170
Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization
NCT03182530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There lacks a larger randomized study of the safety of mobilizing patients immediately after CAG and after PCI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate mobilization
Immediate mobilization after coronary angiography or percutaneous coronary intervention
Immediate mobilization
Patients are mobilized immediate after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device. Heparin reverted with Protaminsulphate
Two hours bedrest
Bedrest two hours after coronary angiography or percutaneous coronary intervention
Two hours bedrest
Patients is following the usual regimen, two hours bedrest after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device before mobilization. Heparin is reverted with Protaminsulphate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immediate mobilization
Patients are mobilized immediate after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device. Heparin reverted with Protaminsulphate
Two hours bedrest
Patients is following the usual regimen, two hours bedrest after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device before mobilization. Heparin is reverted with Protaminsulphate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No hematoma in the groin (\> 5 cm in diameter)
* Heparin reversed with protamine after PCI
Exclusion Criteria
* Treatment with Integrilin, ReoPro, or Marevan
* Heparin can not be reversed
* The patient does not want to participate
* Systolic blood pressure \> 180 mm Hg after the procedure
* BMI\> 35 (can be modified if the groin can be assessed in an upright position)
* Demented, unconscious patients who do not understand the information for participants.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marianne Wetendorff Noergaard
Clinical Nurse Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marianne W Moergaard, MVO
Role: PRINCIPAL_INVESTIGATOR
Cardiac Cath.lab. Copenhagen University Hospital, Rigshospitalet, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital, Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Norgaard MW, Faerch J, Joshi FR, Hofsten DE, Engstrom T, Kelbaek H. Is It Safe to Mobilize Patients Very Early After Transfemoral Coronary Procedures? (SAMOVAR): A Randomized Clinical Trial. J Cardiovasc Nurs. 2022 Sep-Oct 01;37(5):E114-E121. doi: 10.1097/JCN.0000000000000845. Epub 2021 Jul 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAMOVAR 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.